期刊文献+

HPLC测定盐酸托莫西汀的含量 被引量:4

Determination of Atomoxetine Hydrochloride by HPLC
下载PDF
导出
摘要 目的:建立高效液相色谱(HPLC)测定盐酸托莫西汀含量的方法。方法采用氰基键合硅胶色谱柱(Eclipse XDB-CN,5μm,250 mm×4.6 mm),以磷酸缓冲液-甲醇(46:54)为流动相,等度洗脱,流速1.0 mL/min,检测波长210 nm。结果线性范围为40.032-60.048μg/mL,r=0.9999;回收率为99.63%-100.80%,总体RSD=0.37%(n=9)。结论本方法简单、迅速、可靠,可用于盐酸托莫西汀的检测和质量控制。 Objective To establish an HPLC method for the determination of atomoxetine hydrochloride.Methods The cyano bonded silica gel column (Eclipse XDB-CN, 5μm, 250 mm×4.6 mm) was used. The isocratic elution was adopted with the mobile phase composed of PBS and methanol (46:54). The flow rate was 1.0 mL/min and the detective wavelength was 210 nm.Results The linear range of atomoxetine hydrochloride was 40.032-60.048μg/mL and the regression coefficient was 0.9999. The recovery was 99.63 %-100.80 % withRSD of 0.37 % (n=9). Conclusion The method can be simple, quick and reliable. It can be used for the detection and quality control of atomoxetine hydrochloride.
出处 《食品与药品》 CAS 2016年第6期417-420,共4页 Food and Drug
关键词 高效液相 盐酸托莫西汀 含量 high performance liquid chromatography (HPLC) atomoxetine hydrochloride content
  • 相关文献

参考文献5

二级参考文献32

  • 1魏宏伟.治疗注意缺陷障碍的新药——托莫西汀[J].国外医学(儿科学分册),2004,31(6):329-332. 被引量:10
  • 2杜蕾,马培奇.盐酸托莫西汀及其市场展望[J].中国制药信息,2005,21(7):13-15. 被引量:1
  • 3伍季,王华栋,刘红伟,屈凌波.紫外分光光度法测定盐酸托莫西汀胶囊的含量[J].河南科学,2006,24(3):356-357. 被引量:5
  • 4王华栋,吕和平,吴拥军,屈凌波.化学发光法快速测定盐酸托莫西汀的含量[J].药物分析杂志,2007,27(3):348-350. 被引量:6
  • 5Jasiinski D R, Faries D E, Moore R J, et al. Abuse liability assessment of atomoxetine in a drug-abusing population [J]. Drug and Alcohol Dependence,2008, (95) : 140 - 146.
  • 6国家药典委员会.中国药典[K].北京:化学工业出版社,2005.
  • 7Aly F A, Alarfaj N A, Alwarthan A A. Flow injection chemiluminometric analysis of some benzamides by their sensitizing effect on the cerium - sulphite reaction. Talanta,2001,54; 715
  • 8周海钧主译.药品注册的国际技术要求:质量部分(ICH 指导委员会).北京:人民卫生出版社,2000.88
  • 9Bymaster FP,Katner J S,Nelson DL, et al. Atomoxetine increases extracellular levelsof norepinephine and dopamine in prefrontal cortex of rat:a potential mechanism for efficacy attention deficit hyperactivity disorder [J]. Neuropsychopharmecology, 2002,27 (5) :699-711.
  • 10Wang YF, Zheng Y, Du YS, et al. Atomoxetlne versus methylphenidate in pediatric outpatient with attention deficit hyperactivity disorder: a randomized, double-blind comparison trial[J]. Aust N Z J Psychiatry, 2007,41(3) : 222-230.

共引文献25

同被引文献34

引证文献4

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部